4.7 Article

The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER

期刊

JOURNAL OF CELL BIOLOGY
卷 186, 期 5, 页码 685-692

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200906110

关键词

-

资金

  1. Medical Research Council
  2. Wellcome Trust
  3. Newton Trust
  4. Cambridge Biomedical Research Centre
  5. MRC [G9800943, G0600823] Funding Source: UKRI
  6. Medical Research Council [G9800943, G0600823] Funding Source: researchfish

向作者/读者索取更多资源

The US2 and US11 gene products of human cytomegalovirus promote viral evasion by hijacking the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway. US2 and US11 initiate dislocation of newly translocated major histocompatibility complex class I (MHC I) from the ER to the cytosol for proteasome-mediated degradation, thereby decreasing cell surface MHC I. Despite being instrumental in elucidating the mammalian ERAD pathway, the responsible E3 ligase or ligases remain unknown. Using a functional small interfering RNA library screen, we now identify TRC8 ( translocation in renal carcinoma, chromosome 8 gene), an ER-resident E3 ligase previously implicated as a hereditary kidney cancer gene, as required for US2-mediated MHC I ubiquitination. Depletion of TRC8 prevents MHC I ubiquitination and dislocation by US2 and restores cell surface MHC I. TRC8 forms an integral part of a novel multiprotein ER complex that contains MHC I, US2, and signal peptide peptidase. Our data show that the TRC8 E3 ligase is required for MHC I dislocation from the ER and identify a new complex associated with mammalian ERAD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据